BIO2016: Attends HemaCare Corp. 2016 And Stem Cell Research Meetings

LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation,(OTCBB:HEMA) a leader in cell and tissue collection, processing and cell therapy solutions, today announced that it will be attending two key conferences during the month of June in San Francisco. The first conference, BIO International Convention (BIO), held June 6-9th at the Moscone Center, draws over 15,000 biotechnology and pharma leaders together for a week of intensive networking and partnering to discover new opportunities in drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy, a focus critical to HemaCare.